Dr. John Cush RheumNow

5 years 5 months ago

Real world comparision of baricitinib (n 138) and tofacitinib (n 156) in #RA patients shows at wk 24, BARI out performed TOFA - CDAI remission (40.4 vs 28.3%) and CDAI LDA (81.6 vs 69.3%); safety signals were equal between groups. https://t.co/0quNNGB18K

https://bit.ly/3vAHu4l

Dr. John Cush RheumNow

5 years 5 months ago

Top April Tweet: Serious problem! Pulmonologists believe that MTX causes and/or worsens ILD. MTX causes hypersensitivity pneumonitis, not ILD. RA, lupus DM, PSS cause ILD and may need MTX to manage their disease. Research, look at this paper to start. https://t.co/8812FN2b8Q https://t.co/m9lCkYBnyb

https://bit.ly/3nK5Beb

Dr. John Cush RheumNow

5 years 5 months ago

News Features: Seven Year Delay in Diagnosing Spondyloarthritis A large patient cohort study suggests that the mean diagnostic delay (DD) in European axSpA patients is 7.4 years, moreso in women and younger patients. https://t.co/m2yIkrwcFA https://t.co/N7Z0BUeBUN

https://bit.ly/3vvWUqB

Dr. John Cush RheumNow

5 years 5 months ago

News Feature: Psoriatic Pregnancies Pose Risks to the Mother, Not Child A metanalysis of pregnancy outcomes in women with psoriasis and psoriatic arthritis finds an excess risk of adverse maternal events, but not adverse neonatal events. https://t.co/kZE2yLEvm7 https://t.co/OYQhM10csl

https://bit.ly/3gGYLVl

Dr. John Cush RheumNow

5 years 5 months ago

Have you had the chance to listen to last week's podcast? We have news of Uppers and Downers. Hear about vaccine success, CKD gout prophylaxis, TOFA in AS & too much IL-17 inhib can be a problem https://t.co/kt63YrQ0Sw Listen iTunes> https://t.co/FHJv01AAbC or Android SoundCloud https://t.co/jbeNhYUdqz

Higher Cardiovascular Risks with Systemic Lupus Erythematosus

Jack Cush, MD

5 years 5 months ago

The Journal of the American College of Cardiology has published the results of a study showing that patients with systemic lupus erythematosus (SLE) have an increased risk of heart failure (HF) and other long-term cardiovascular outcomes.

Uric Acid: A Major Player in the Metabolic Syndrome

Jack Cush, MD

5 years 5 months ago

An open source, free read from the European Journal of Internal Medicine discusses how uric acid has evolved from the toxic cause of gout and nephrolithiasis and evolved, by way of science, into a pleiotropic recidivist in the evolution of obesity, diabetes, insulin resistance, renal disease, hypertension, fatty liver, and cardiovascular disease.

Dr. John Cush RheumNow

5 years 5 months ago

Tomorrow--join us for Tuesday Night Rheumatology focusing on Psoriatic Arthritis with Dr. Eric Ruderman, Melodie Young, and Dr. Alexis Ogdie Beatty. https://t.co/9S3dKnZ9to https://t.co/dPmw9eklQz

https://bit.ly/3efnoGY

Dr. John Cush RheumNow

5 years 5 months ago

Nested case–control study from the Danish (DANBIO) Register and 8019 Psoriatic arthritis patients shows that pain alone does not influence mortality risk; however steroid and comorbidities do! https://t.co/74haeSXwXn